Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight

U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07893093) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Formulations of ASC36 Injection in Participants With Obesity or Overweight' on Oct. 19.

Brief Summary: This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of Two Formulations of ASC36 injection

Study Start Date: Sept. 28

Study Type: INTERVENTIONAL

Condition: Chronic Weight Management

Intervention: DRUG: ASC36 Injection A, for subcutaneous use

ASC36 Injection A is an investigational form...